top of page

Weifei Luo

Chief Technology Officer at AIage Life Science Corporation

Dr. Weifei Luo has received a Ph.D. in Biochemistry from University of Colorado Anschutz Medical Campus in 2006. Afterwards, he studied the mechanism of circadian rhythm and sleep at the laboratory of Nobel Laureate Dr. Michael Rosbash at Howard Hughes Medical Institute. In 2020, Dr. Luo returned to Guangxi, China, “towns of Longevity” and led a group of scientists to unravel gut microbiome and longevity and discovered that centenarians have a youth-like signature in their gut microbiome, which was published in Nature Aging in April 2023.
With his strong scientific background,entrepreneurial mindsets, and the passion for helping people achieve healthy longevity, Dr. Luo co-found AIage Life Science and serves as President, Chief Technology officer and Chief Product Officer. His goal is to bring innovative and effective microbiome supplements with a focus on anti-aging, longevity and aging-related diseases to the market.
Dr. Luo is the director of Guangxi Key Laboratory of Longevity Science and Technology. His expertise spans in the fields of gene expression and RNA biogenesis, neurobiology of circadian rhythm and sleep, microbiome, anti-aging and longevity. He has published multiple research papers in top-ties journals such as Cell, Nature and Nature Aging and and the inventors of over 60 patent inventions. Outside of work, Dr. Luo enjoys time with his family, spends time in nature, and likes to cook healthy meals.

LI Final Color.png

Thanks for submitting!

  • X
  • LinkedIn
  • Instagram

© 2024 by Longevity Investors Ltd.

bottom of page